Cancer Survivorship Algorithms
Survivorship algorithms depict best practices for care delivery by providing patient management tools to patients under surveillance for cancer recurrence and secondary cancers. Patients are transitioned to Survivorship once there is no evidence of disease for a specific time period dependent on the patient’s cancer site. These algorithms are not intended to replace the independent medical judgment of the physician in the context of individual clinical circumstances to determine a patient's care.
Survivorship Screening
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
- Bladder Cancer
- Kidney Cancer
- Penile Cancer
- Prostate Cancer
- Testicular Cancer - Germ Cell
- Germ Cell Seminoma Stage I Surveillance
- Germ Cell Seminoma Stage I - Post Adjuvant Radiotherapy or Single-Agent Carboplatin
- Germ Cell Non-Seminoma Stage I Surveillance
- Germ Cell Non-Seminoma Stage I - Post RPLND and/or Adjuvant Chemotherapy
- Germ Cell - All Types, Stages II-IV
Gynecologic Cancer
Head and Neck Cancer
- Benign Salivary Gland Tumor
- Larynx/Hypopharynx Cancer
- Nasopharynx Cancer
- Oral Cavity Cancer
- Oropharynx Cancer
- Salivary Cancer
- Unknown Primary
Leukemia
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myelogenous Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
Lung
Lymphoma
- Diffuse Large B-Cell Lymphoma
- Follicular B-Cell Lymphoma for Stage I or II
- Hodgkin Lymphoma
- Peripheral T-Cell Lymphoma
Melanoma
Sarcoma
Thyroid Cancer
We're here for you.
Call us at
1-877-632-6789
or
request an appointment online.
request an appointment online.
Let's get started.
Request an appointment online.
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.